Gene expression of hENT1, dCK, CDA, dCMPD and topoisomerase IIα as an indicator of chemotherapy response in AML treated with cytarabine and daunorubicin

Gene expression of hENT1, dCK, CDA, dCMPD and topoisomerase IIα as an indicator of chemotherapy response in AML treated with cytarabine and daunorubicin

Bibi Kulsoom,1,2 Tahir Sultan Shamsi,1 Nasir Ali Afsar3 1Center of Excellence in Molecular Medicine, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan; 2Department of Biochemistry, Jinnah Medical and Dental College, Karachi, Pakistan; 3Department of Pharmacology...

Full description

Bibliographic Details
Main Authors: Kulsoom B, Shamsi TS, Afsar NA
Format: Article
Language:English
Published: Dove Medical Press 2018-11-01
Series:Cancer Management and Research
Subjects:
Topoisomerase II
hENT1
dCMPD
CDA
dCK
survival
AML
Online Access:https://www.dovepress.com/gene-expression-of-hent1-dck-cda-dcmpd-and-topoisomerase-iialpha-as-an-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/gene-expression-of-hent1-dck-cda-dcmpd-and-topoisomerase-iialpha-as-an-peer-reviewed-article-CMAR

Similar Items